Leading The Way With Research
Since the Lustgarten Foundation was established in 1998, we have been committed to changing outcomes so patients have a better chance for long-term survival. From basic science to the clinic, our funded researchers are investigating ways to detect the disease earlier, personalize treatment and develop better therapies. We make large-scale commitments to leading pancreatic cancer researchers at the finest institutions, funding studies that seek to continually stretch the boundaries of science. We have a focused and unique research strategy which encompasses four key drivers:
Focus on Patients
Advance research to deliver improved outcomes for patients.
Increase the impact of funding through the coordination of academic work with translational groups, industry and clinicians.
Expand the impact of Foundation funds by matching investments of partners and industry.
Recruit the best experts in the world from a variety of disciplines and fields to work on pancreatic cancer.
Using these drivers as a guide, we have invested millions of dollars through our dedicated Lustgarten Foundation Pancreatic Cancer Research Laboratory at Cold Spring Harbor Laboratory, as well as major research grant programs which includes the Translational Clinical Program, Research Investigator Program, Distinguished Scholar Program and the Pancreatic Cancer Collective which is our partnership with Stand Up To Cancer. Our research encompasses all areas of pancreatic cancer: earlier detection, personalized medicine; and drug development. We fund research at every stage of the process from basic/pre-clinical research to clinical studies and trials. Many of our projects span more than one topic area. In order for the work to be impactful, it must be inter connected and collaborative.
- Early Detection
- Personalized Medicine
- Drug Development
“We now know enough about pancreatic cancer to think about overcoming it because the history of medicine is that once one understands the disease, it’s only a matter of time before that disease is conquered.” – Bert Vogelstein, M.D., Lustgarten Foundation Distinguished Scholar